Literature DB >> 35129693

Tobramycin Stress Induced Differential Gene Expression in Acinetobacter baumannii.

Shruti Kashyap1, Prince Sharma2, Neena Capalash3.   

Abstract

Acinetobacter baumannii is a multidrug-resistant bacteria responsible for nosocomial infections with significant fatality rates globally. Therapeutic failure and relapse of infection has been associated with persister cells formation which can also lead to resistance in A. baumannii. In the present study, we observed that A. baumannii ATCC 17978 in exponential phase survived lethal concentrations of amikacin, rifampicin and ciprofloxacin by generating persister cells but was unable to survive tobramycin treatment. The transcriptome of A. baumannii ATCC 17978 was analyzed following exposure to a high concentration of tobramycin (10 × MIC) for a short period of time to study the possible mechanisms responsible for lethality. Tobramycin reduced the expression of genes involved in energy production (nuoH, nuoN, nuoM, cydA, sucC), oxidative stress protection (tauD, cysD), and nutrition uptake (ompW) significantly. In addition, hemerythrin (non-heme di-iron oxygen-binding protein) was found to be the most downregulated gene in response to tobramycin which needs to be further studied for its role in susceptibility to antibiotics. Tobramycin upregulated the expression of genes that are mainly involved in stress response (leucine catabolism, DNA repair and HicAB toxin-antitoxin system). The differentially expressed genes highlighted in the study provided insight into the probable molecular mechanism of tobramycin-induced cell death and revealed some novel targets that can be explored further for their potential to control A. baumannii.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35129693     DOI: 10.1007/s00284-022-02788-7

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  41 in total

Review 1.  Formation, physiology, ecology, evolution and clinical importance of bacterial persisters.

Authors:  Bram Van den Bergh; Maarten Fauvart; Jan Michiels
Journal:  FEMS Microbiol Rev       Date:  2017-05-01       Impact factor: 16.408

Review 2.  Insights into Acinetobacter baumannii pathogenicity.

Authors:  Gustavo M Cerqueira; Anton Y Peleg
Journal:  IUBMB Life       Date:  2011-10-12       Impact factor: 3.885

3.  Combination of polymyxin B and meropenem eradicates persister cells from Acinetobacter baumannii strains in exponential growth.

Authors:  Stephanie W Gallo; Carlos Alexandre S Ferreira; Sílvia D de Oliveira
Journal:  J Med Microbiol       Date:  2017-07-19       Impact factor: 2.472

Review 4.  Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

5.  Determining the Development of Persisters in Extensively Drug-Resistant Acinetobacter baumannii upon Exposure to Polymyxin B-Based Antibiotic Combinations Using Flow Cytometry.

Authors:  Fiona Hui-Sian Wong; Yiying Cai; Hui Leck; Tze-Peng Lim; Jocelyn Qi-Min Teo; Winnie Lee; Tse Hsien Koh; Thuan Tong Tan; Kar Wai Tan; Andrea Lay-Hoon Kwa
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 6.  Managing Acinetobacter baumannii infections.

Authors:  José Garnacho-Montero; Jean-François Timsit
Journal:  Curr Opin Infect Dis       Date:  2019-02       Impact factor: 4.915

7.  Characterization and Transcriptome Analysis of Acinetobacter baumannii Persister Cells.

Authors:  Rashad Alkasir; Yanan Ma; Fei Liu; Jing Li; Na Lv; Yong Xue; Yongfei Hu; Baoli Zhu
Journal:  Microb Drug Resist       Date:  2018-06-14       Impact factor: 3.431

8.  Pyocyanin stimulates quorum sensing-mediated tolerance to oxidative stress and increases persister cell populations in Acinetobacter baumannii.

Authors:  Nidhi Bhargava; Prince Sharma; Neena Capalash
Journal:  Infect Immun       Date:  2014-06-02       Impact factor: 3.441

9.  Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

Authors:  Evelina Tacconelli; Elena Carrara; Alessia Savoldi; Stephan Harbarth; Marc Mendelson; Dominique L Monnet; Céline Pulcini; Gunnar Kahlmeter; Jan Kluytmans; Yehuda Carmeli; Marc Ouellette; Kevin Outterson; Jean Patel; Marco Cavaleri; Edward M Cox; Chris R Houchens; M Lindsay Grayson; Paul Hansen; Nalini Singh; Ursula Theuretzbacher; Nicola Magrini
Journal:  Lancet Infect Dis       Date:  2017-12-21       Impact factor: 71.421

Review 10.  Definitions and guidelines for research on antibiotic persistence.

Authors:  Nathalie Q Balaban; Sophie Helaine; Kim Lewis; Martin Ackermann; Bree Aldridge; Dan I Andersson; Mark P Brynildsen; Dirk Bumann; Andrew Camilli; James J Collins; Christoph Dehio; Sarah Fortune; Jean-Marc Ghigo; Wolf-Dietrich Hardt; Alexander Harms; Matthias Heinemann; Deborah T Hung; Urs Jenal; Bruce R Levin; Jan Michiels; Gisela Storz; Man-Wah Tan; Tanel Tenson; Laurence Van Melderen; Annelies Zinkernagel
Journal:  Nat Rev Microbiol       Date:  2019-07       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.